Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study)
Condition: HIV Infections Intervention: Sponsors: ANRS, Emerging Infectious Diseases; CIRBA, Abidjan, Ivory Coast; SEREFO, Bamako, Mali; BIOLIM/FSS/UL, Lomé, Togo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 6, 2022 Category: Research Source Type: clinical trials
MULTIple Doses of IPTi Proposal: a Lifesaving High Yield Intervention
Condition: Malaria,Falciparum Intervention: Drug: Intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine Sponsors: Barcelona Institute for Global Health; Institut de Recherche pour le Developpement; Centro de Investigacao em Saude de Manhica; Medicines for Malaria Venture; University of Lomé (UL), Togo; University of Sierra Leone Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2021 Category: Research Source Type: clinical trials
